4//SEC Filing
Broadfin Healthcare Master Fund Ltd 4
Accession 0001103021-21-000120
CIK 0001103021other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 7:37 AM ET
Size
9.0 KB
Accession
0001103021-21-000120
Insider Transaction Report
Form 4
KOTLER KEVIN
Director
Transactions
- Purchase
Common Stock
2021-11-19$3.06/sh+100,000$306,000→ 5,158,489 total(indirect: See footnote)
Footnotes (2)
- [F1]4,400,689 shares of Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Broadfin Healthcare Master Fund, Ltd., Broadfin Capital, LLC, and Kevin Kotler affirmatively (i) disclaim beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of1934, as amended (the "Act") or any other purpose, except to the extent of their pecuniary interest therein, and (iii) disclaim being a "group" for purposes of Section 16.
- [F2]757,800 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001511900
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 7:37 AM ET
- Size
- 9.0 KB